日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P-345. Prevalence of Integrase HIV-1 Drug Resistance Mutations in the United States: 2019-2024

P-345. 美国 HIV-1 整合酶耐药突变流行情况:2019-2024 年

Kaczmarek, Agata; Żok, Agnieszka; Baum, Ewa; Henegar, Cassidy; Lai, Johnny; Brown, Kimberley; Jones, Bryn; de Ruiter, Annemiek; Sridhar, Gayathri; Underwood, Mark; Walworth, Charles M; Vannappagari, Vani

P-1076. Describing the Clinical Epidemiology of Metallo-β-lactamase–producing (MBL) Carbapenem-resistant Enterobacterales at a Large Health System

P-1076. 描述大型医疗系统中产金属β-内酰胺酶(MBL)的耐碳青霉烯类肠杆菌的临床流行病学

Saccomanno, Jacopo; Elgeti, Thomas; Spiegel, Stephanie; Pappe, Eva; Sgarbossa, Thomas; Petersen, Antonia; Neumann, Konrad; Mall, Marcus A; Witzenrath, Martin; Hübner, Ralf-Harto; Yan, Lei; Henegar, Cassidy; Cheung, Kei-Hoi; Marconi, Vincent; Rodriguez-Barradas, Maria C; Ragone, Leigh; Jones, Bryn; Vannappagari, Vani; Justice, Amy; Aslan, Mihaela; Polashenski, Maya; Lebreton, Francois; Bennett, Jason; Mozafari, Moein; West, Jennifer; Stam, Jason; Pence, Robert; Kwak, Yoon; McGann, Patrick; Lesho, Emil P; Hiddemann, M; Koehler, K; Becher, M; Roemmelt, C; Zernikow, J; Bekfani, T; Schneider, D; Winkler, S; Melzer, C; Hinrichs, N; Meyer, A; Dagres, N; Hindricks, G; Spethmann, S; Koehler, F; Rathod, Shardul N; Hareza, Dariusz A; Kling, Kendall

Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study

COMBINE-2 研究数据:在病毒学抑制的 HIV 感染者队列中,含整合酶抑制剂和逆转录酶抑制剂的双药方案的有效性和安全性

Mussini, Cristina; Henegar, Cassidy; Assoumou, Lambert; de Wit, Stephane; Johnson, Margaret; Quiros-Roldan, Eugenia; Kenyon, Chris; Deschanvres, Colin; Zucman, David; Post, Frank; Movahedi, Roya; Comi, Laura; Fox, Julie; Liegeon, Geoffrey; Martin, Charlotte; Edwards, Jonathan; Tiecco, Giorgio; Delforge, Marc; Ragone, Leigh; Jones, Bryn; van Wyk, Jean; Aboud, Michael; Fletcher, Carl; Pozniak, Anton; Vannappagari, Vani

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

通过联合使用NAMPT抑制剂和双硫仑来靶向代谢脆弱性,治疗复发性卵巢癌

Kei Kudo ,Yoshimi Endo Greer ,Daniel R Crooks ,Ye Yang ,Jeffrey R Brender ,Teruhiko Yoshida ,Brittney S Harrington ,Rahul Kamdar ,Soumya Korrapati ,Yusuke Shibuya ,Leah Henegar ,Jeffrey Kopp ,Takeo Fujii ,Stanley Lipkowitz ,Christina M Annunziata

Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study

美国常规临床护理中福斯特沙韦的免疫学和病毒学反应:一项OPERA队列研究

Hsu, Ricky K; Brunet, Laurence; Lackey, Philip C; Pierone, Gerald Jr; Levis, Brooke; Fusco, Jennifer S; Henegar, Cassidy; Vannappagari, Vani; Clark, Andrew; Fusco, Gregory P

Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeks

在为期 96 周的随机试验中,多替拉韦或对照抗逆转录病毒疗法对高血压和血压变化的影响

Patel, Parul; Milinkovic, Ana; Grove, Richard; Govan, Lindsay; McKenna, Michael; Wynne, Brian; Henegar, Cassidy; Martinez, Esteban; Dimondi, Paul; Chow, Ken; Payvandi, Nassrin; Jones, Bryn

Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With HIV on Dolutegravir in Europe and Thailand

欧洲和泰国儿童及青少年艾滋病毒感染者接受多替拉韦治疗的病毒抑制、病毒治疗失败及安全性结果

Scott, Karen; O'Rourke, John; Jackson, Charlotte; Ene, Luminita; Galli, Luisa; Goetghebuer, Tessa; Henegar, Cassidy; Königs, Christoph; Marczyńska, Magdalena; Naver, Lars; Noguera-Julian, Antoni; Paioni, Paolo; Ramos, Jose T; Smith, Birgitte; Songtaweesin, Wipaporn Natalie; Spoulou, Vana; Tantawarak, Nattakarn; Turkova, Anna; Vannappagari, Vani; Volokha, Alla; Bamford, Alastair; Castro, Hannah; Chappell, Elizabeth; Dalla Valle, Giorgia; Foster, Caroline; Guillén Martín, Sara; Prieto Tato, Luis Manuel; Puthanakit, Thanyawee; Sherstiuk, Halyna; Shkurka, Irina; Soeria-Atmadja, Sandra; Judd, Ali; Crichton, Siobhan; Collins, Intira Jeannie

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

双重抑制NAMPT和PAK4可在铂耐药卵巢癌的3D球体模型中诱导抗肿瘤作用

Kei Kudo ,Yoshimi Endo Greer ,Teruhiko Yoshida ,Brittney S Harrington ,Soumya Korrapati ,Yusuke Shibuya ,Leah Henegar ,Jeffrey B Kopp ,Takeo Fujii ,Stanley Lipkowitz ,Christina M Annunziata

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

病毒学抑制后改用多替拉韦/拉米夫定双药方案与改用美国常用的三药方案的比较

Pierone, Gerald; Fusco, Jennifer S; Brunet, Laurence; Vannappagari, Vani; Sarkar, Supriya; Henegar, Cassidy E; van Wyk, Jean; Wohlfeiler, Michael B; Mills, Anthony; Fusco, Gregory P

Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS)

在退伍军人老龄化队列研究 (VACS) 中,多替拉韦方案与拉替拉韦、埃尔维格拉韦、比克替拉韦和达芦那韦方案在老年 HIV 感染者中的疗效比较

Yan, Lei; Henegar, Cassidy E; Marconi, Vincent C; Gordon, Kirsha S; Hicks, Charles; Vannappagari, Vani; Justice, Amy C; Aslan, Mihaela